1DAS U N.Angiotensin-Ⅱ behaves as an endogenous pro-inflammatory molecule[J].J Assoc Physicians India,2005,53(6):472-476. 被引量：1
2SCHMERMUND A,WIENEKE H,ERBEL R.Medical treatment of athe-rosclerosis[J].Med Monatsschr Pharm(德文),2005,28(9):300-308. 被引量：1
3WILLIAMS K J,LIU M L,ZHU Y,et al.Loss of heparan N-sulfotransferase in diabetic liver:role of angiotensin Ⅱ[J].Diabetes,2005,54(4):1116-1122. 被引量：1
4WAGNER A,HERKNER H,SCHREIBER W,et al.Ramipril prior to thrombolysis attenuates the early increase of PAI-1 in patients with acute myocardial infarction[J].Thromb Haemost,2002,88(2):180-185. 被引量：1
5SCHIEFFER B,BUNTE C,WITTE J,et al.Comparative effects of AT1-antagonism and angiotensin-converting enzyme inhibition on markers of inflammation and platelet aggregation in patients with coronary artery disease[J].J Am Coll Cardiol,2004,44(2):362-368. 被引量：1
6BAURIEDEL G,SKOWASCH D,SCHNEIDER M,et al.Antiplatelet effects of angiotensin-converting enzyme inhibitors compared with aspirin and clopidogrel:a pilot study with whole-blood aggregometry[J].Am Heart J,2003,145(2):343-348. 被引量：1
